1. Home
  2. FULC vs LOCO Comparison

FULC vs LOCO Comparison

Compare FULC & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulcrum Therapeutics Inc.

FULC

Fulcrum Therapeutics Inc.

HOLD

Current Price

$6.98

Market Cap

467.8M

Sector

Health Care

ML Signal

HOLD

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$13.96

Market Cap

411.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULC
LOCO
Founded
2015
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
467.8M
411.3M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
FULC
LOCO
Price
$6.98
$13.96
Analyst Decision
Buy
Buy
Analyst Count
8
4
Target Price
$16.38
$14.17
AVG Volume (30 Days)
677.6K
193.5K
Earning Date
04-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.65
EPS
N/A
0.90
Revenue
N/A
$401,701,000.00
Revenue This Year
N/A
$3.60
Revenue Next Year
N/A
$3.98
P/E Ratio
N/A
$14.96
Revenue Growth
N/A
5.68
52 Week Low
$5.47
$8.87
52 Week High
$15.74
$14.50

Technical Indicators

Market Signals
Indicator
FULC
LOCO
Relative Strength Index (RSI) 40.99 58.88
Support Level $6.39 $13.42
Resistance Level $7.09 $14.38
Average True Range (ATR) 0.47 0.44
MACD -0.06 -0.05
Stochastic Oscillator 10.81 38.90

Price Performance

Historical Comparison
FULC
LOCO

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

Share on Social Networks: